Trial intelligence / Profile preview

Buffered vs. Non-Buffered Lidocaine in Dental Procedures

NCT02620683Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Dec 2015
Primary completion
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Lidocaine Blood Levels 30 Minutes Post Injection at 30 months. Started Dec 2015; status: completed.

02

Drugs

lidocaine

Beyond the preview

Go deeper on NCT02620683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02620683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call